Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T W Barrowcliffe

Showing results (61-70 of 159) with videos related to

Pageof 16
Sort By:
The Journal of Laboratory and Clinical Medicine|January 1, 1983
Binding to phospholipid protects factor VIII from inactivation by human antibodiesT W Barrowcliffe, G Kemball-Cook, E Gray
Thrombosis and Haemostasis|May 9, 2001
Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586)A R Hubbard, P Rigsby, T W Barrowcliffe
Thrombosis Research|January 1, 1981
Factor VIII inhibitor bypassing activity: a suggested mechanism of actionT W Barrowcliffe, G Kemball-Cook, E Gray
British Journal of Haematology|September 1, 1983
Studies of the heterogeneity of antithrombin III concentratesT W Barrowcliffe, C A Eggleton, M Mahmoud
Thrombosis and Haemostasis|December 1, 1996
Collaborative study on assays of activated FIX (FIXa). On behalf of the factor VIII and factor IX subcommittee of the ISTH. International Society on Thrombosis and HaemostasisE Gray, D Walker, A Heath, et al.
Thrombosis and Haemostasis|February 29, 1980
An international collaborative study establishing a reference preparation for Antithrombin IIIT B Kirkwood, T W Barrowcliffe, D P Thomas
Thrombosis Research|September 1, 1984
Anticoagulant properties in vitro of heparan sulphatesA R Hubbard, C A Jennings, T W Barrowcliffe
Journal of Clinical Pathology|December 1, 1973
Proceedings: Platelet aggregation with ristocetinJ Hughes, E Wilson, T W Barrowcliffe, et al.
Thrombosis and Haemostasis|September 1, 1993
Evaluation of factor VIII deficient plasmasT W Barrowcliffe, J E Tubbs, M Y Wong
British Journal of Haematology|March 4, 2006
Guidelines on the use and monitoring of heparinT Baglin, T W Barrowcliffe, A Cohen, et al.
Pageof 16

Showing results (61-70 of 159) with videos related to

Sort By:
Pageof 16
The Journal of Laboratory and Clinical Medicine|January 1, 1983
Binding to phospholipid protects factor VIII from inactivation by human antibodiesT W Barrowcliffe, G Kemball-Cook, E Gray
Thrombosis and Haemostasis|May 9, 2001
Standardisation of factor VIII and von Willebrand factor in plasma: calibration of the 4th International Standard (97/586)A R Hubbard, P Rigsby, T W Barrowcliffe
Thrombosis Research|January 1, 1981
Factor VIII inhibitor bypassing activity: a suggested mechanism of actionT W Barrowcliffe, G Kemball-Cook, E Gray
British Journal of Haematology|September 1, 1983
Studies of the heterogeneity of antithrombin III concentratesT W Barrowcliffe, C A Eggleton, M Mahmoud
Thrombosis and Haemostasis|December 1, 1996
Collaborative study on assays of activated FIX (FIXa). On behalf of the factor VIII and factor IX subcommittee of the ISTH. International Society on Thrombosis and HaemostasisE Gray, D Walker, A Heath, et al.
Thrombosis and Haemostasis|February 29, 1980
An international collaborative study establishing a reference preparation for Antithrombin IIIT B Kirkwood, T W Barrowcliffe, D P Thomas
Thrombosis Research|September 1, 1984
Anticoagulant properties in vitro of heparan sulphatesA R Hubbard, C A Jennings, T W Barrowcliffe
Journal of Clinical Pathology|December 1, 1973
Proceedings: Platelet aggregation with ristocetinJ Hughes, E Wilson, T W Barrowcliffe, et al.
Thrombosis and Haemostasis|September 1, 1993
Evaluation of factor VIII deficient plasmasT W Barrowcliffe, J E Tubbs, M Y Wong
British Journal of Haematology|March 4, 2006
Guidelines on the use and monitoring of heparinT Baglin, T W Barrowcliffe, A Cohen, et al.
Pageof 16